Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jan;4(1):4-11.
doi: 10.1016/j.nurt.2006.11.005.

Currently available antiepileptic drugs

Affiliations
Review

Currently available antiepileptic drugs

Steven C Schachter. Neurotherapeutics. 2007 Jan.

Abstract

Many new antiepileptic drugs (AEDs) have become available over the past 15 years. At the same time, the emphasis on treating patients with epilepsy has grown from stopping seizures to avoiding side effects and maximizing quality of life. This review summarizes currently available AEDs, and presents general treatment principles and guidelines for AED selection. Unfortunately, despite the increased treatment options of today, seizure freedom without side effects remains unattainable for too many patients with epilepsy. Consequently, there remains a significant need for further development of new therapies.

PubMed Disclaimer

References

    1. Schachter SC. Quality of life for patients with epilepsy is determined by more than seizure control: the role of psychosocial factors. Expert Rev Neurother. 2006;6:111–118. doi: 10.1586/14737175.6.1.111. - DOI - PubMed
    1. Schachter SC. Improving quality of life beyond seizure control. Epileptic Disord. 2005;7(suppl 1):34–38. - PubMed
    1. Asconape JJ. Some common issues in the use of antiepileptic drugs. Semin Neurol. 2002;22:27–39. doi: 10.1055/s-2002-33046. - DOI - PubMed
    1. Brodie MJ, Schachter SC, Kwan P. Epilepsy. 3rd ed. Oxford, England: Health Press; 2005.
    1. Levy RH, Mattson RH, Meldrum BS, Perucca E. Antiepileptic drugs. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2002.

Substances